The regulator claims the dispute is “much ado about nothing,” noting that the order allows any designated contract market, including CME, to list these products.
Read the full article here
Verify the accuracy of this article using AI-powered analysis and real-time sources.
Enter your email to receive detailed fact-checking analysis
You've used your 5 free reports. Sign up for unlimited access!
Already have an account? Sign in here
The FSNN News Room is the voice of our in-house journalists, editors, and researchers. We deliver timely, unbiased reporting at the crossroads of finance, cryptocurrency, and global politics, providing clear, fact-driven analysis free from agendas.
We and our selected partners wish to use cookies to collect information about you for functional purposes and statistical marketing. You may not give us your consent for certain purposes by selecting an option and you can withdraw your consent at any time via the cookie icon.
Cookies are small text that can be used by websites to make the user experience more efficient. The law states that we may store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies, we need your permission. This site uses various types of cookies. Some cookies are placed by third party services that appear on our pages.
Freedom Index